Publication | Open Access

Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives

Angiokinase InhibitionMedicinePharmacologyCancer GrowthPharmacotherapyTumor TargetingAnti-cancer AgentMolecular DockingRadiation OncologyTumor MicroenvironmentLung CancerTumor BiologyDrug Discovery